APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly ; volume:15 ; number:1 ; day:4 ; month:4 ; year:2023 ; pages:1-15 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (4.4.2023), 1-15, 12.2023
- Urheber
-
Snellman, Anniina
Ekblad, Laura L.
Tuisku, Jouni
Koivumäki, Mikko
Ashton, Nicholas J.
Lantero-Rodriguez, Juan
Karikari, Thomas K.
Helin, Semi
Bucci, Marco
Löyttyniemi, Eliisa
Parkkola, Riitta
Karrasch, Mira
Schöll, Michael
Zetterberg, Henrik
Blennow, Kaj
Rinne, Juha O.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01209-6
- URN
-
urn:nbn:de:101:1-2023081909012806514988
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Snellman, Anniina
- Ekblad, Laura L.
- Tuisku, Jouni
- Koivumäki, Mikko
- Ashton, Nicholas J.
- Lantero-Rodriguez, Juan
- Karikari, Thomas K.
- Helin, Semi
- Bucci, Marco
- Löyttyniemi, Eliisa
- Parkkola, Riitta
- Karrasch, Mira
- Schöll, Michael
- Zetterberg, Henrik
- Blennow, Kaj
- Rinne, Juha O.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
APOE-ε4-related differences in left thalamic microstructure in cognitively healthy adults
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes
Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
APOE-ε4-related differences in left thalamic microstructure in cognitively healthy adults
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes
Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
APOE-ε4-related differences in left thalamic microstructure in cognitively healthy adults
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes
Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism